Good response of glioblastoma in a child with sickle cell anemia supports the therapeutic potential of tumor infarcting agents

  • Authors:
    • J Blatt
    • M Koehler
    • R Towbin
    • L Albright
  • View Affiliations

  • Published online on: September 1, 1996     https://doi.org/10.3892/or.3.5.875
  • Pages: 875-877
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A number of anti-angiogenesis and thrombosing agents are in development for the treatment of a range of cancer types. However, there are few clinical data to support this approach. We reviewed our experience with a child with sickle cell anemia and glioblastoma multiforme to look at a possible contribution of sickling and therefore vascular infarction on tumor control. A 3 1/2-year-old girl with sickle cell anemia, developed a cerebral glioblastoma multiforme. She received 5 cycles of ifosfamide and etoposide as well as 54 Gy local irradiation. Follow-up was monitored with serial MR scans. Four and a half years from diagnosis the child is neurologically normal and has no radiographic evidence of tumor. While we cannot say whether this child did well by chance alone, we hypothesize that local sickling with resultant tumor infarction may have been a factor in her unexpectedly good outcome. Her course lends anecdotal support to the notion that small vessel infarction can play a therapeutic role in the management of solid tumors.

Related Articles

Journal Cover

September 1996
Volume 3 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Blatt J, Koehler M, Towbin R and Albright L: Good response of glioblastoma in a child with sickle cell anemia supports the therapeutic potential of tumor infarcting agents. Oncol Rep 3: 875-877, 1996
APA
Blatt, J., Koehler, M., Towbin, R., & Albright, L. (1996). Good response of glioblastoma in a child with sickle cell anemia supports the therapeutic potential of tumor infarcting agents. Oncology Reports, 3, 875-877. https://doi.org/10.3892/or.3.5.875
MLA
Blatt, J., Koehler, M., Towbin, R., Albright, L."Good response of glioblastoma in a child with sickle cell anemia supports the therapeutic potential of tumor infarcting agents". Oncology Reports 3.5 (1996): 875-877.
Chicago
Blatt, J., Koehler, M., Towbin, R., Albright, L."Good response of glioblastoma in a child with sickle cell anemia supports the therapeutic potential of tumor infarcting agents". Oncology Reports 3, no. 5 (1996): 875-877. https://doi.org/10.3892/or.3.5.875